Taking a GLP-1 drug? Here’s what the safety evidence really shows

by | Oct 26, 2026 | News Feeds

A review on GLP-1 receptor agonists highlights risks like pancreatitis and thyroid cancer, emphasizing individual patient risk over general safety concerns.

Read Original Copy